# Is there a medicine for GLP-1 nausea? Tradipitant, so far

Source: https://pepvault.app/guides/tradipitant-for-glp-1-nausea

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Is there a medicine for GLP-1 nausea? Tradipitant, so far

Reviewed November 2026 15 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

No medicine is approved for GLP-1 nausea yet. Tradipitant, a motion-sickness pill, cut vomiting after semaglutide in phase 3. What it does, and what helps now.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 15
- **Questions:** 8
- **Compounds:** 2

## The short answer

Not yet: none is approved for GLP-1 nausea. The closest is tradipitant, an anti-vomiting pill already approved in the US as Nereus for vomiting caused by motion. In a phase 3 trial reported on October 27, 2026, it cut vomiting after a 1 mg semaglutide shot from 58.5% on placebo to 43.0%. Vanda plans to seek approval. Until then, a slow dose climb, smaller meals and fluids do the work.

Every number checked at its primary source · Nov 20, 2026 · [15 sources](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Two company-run, placebo-controlled trials in people given a single 1 mg semaglutide shot, reported by Vanda in press releases and not yet in a journal; FDA prescribing information for the motion-sickness approval and for Wegovy and Zepbound.

## Is there a medicine for Ozempic or GLP-1 nausea yet?

Not one approved for it. As of November 20, 2026, the FDA has approved no medicine for the nausea or vomiting that GLP-1 shots such as Ozempic, Wegovy, Mounjaro and Zepbound can cause. Furthest along is tradipitant from Vanda Pharmaceuticals, already sold as Nereus, but only to prevent vomiting caused by motion, such as on a boat[6](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-6) [7](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-7). Vanda has finished two placebo-controlled trials in people given semaglutide, the medicine in Ozempic and Wegovy, calls both positive[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) [4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4), and plans to file for a GLP-1 approval[5](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-5).

Today, GLP-1 nausea is handled the way the labels describe: a slow dose climb, a pause in that climb when a step is not tolerated, and plenty of fluids[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) [13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13). Prescribers can also use general anti-sickness medicines case by case, as an expert panel suggests when nausea persists despite diet changes[14](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-14). The last section of this guide sets those steps out.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's side-effect log keeps each symptom with the compound, a severity from minimal to very severe, the date and a note, so you can show your prescriber which step and which days it hit.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What is tradipitant and how does it work?

Tradipitant is an NK1 receptor blocker, taken as a capsule. Substance P is a messenger chemical that helps trigger vomiting when it lands on NK1 receptors, docking points found along the vomiting pathway in the brainstem and the gut[8](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-8) [15](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-15). Tradipitant sits in those receptors so substance P cannot switch them on. Brain scans show it crosses into the brain and occupies its NK1 receptors; the label adds that the exact way it prevents vomiting is not fully worked out[6](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-6).

It is the same class as aprepitant (Emend), an NK1 blocker approved for years to prevent the nausea and vomiting of cancer chemotherapy, used together with other anti-sickness drugs[9](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-9). Tradipitant is a small molecule, not a peptide, and it does not touch the receptors that older anti-sickness drugs work on, such as serotonin, dopamine or histamine receptors[6](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-6). Vanda licensed it from Eli Lilly in 2012[11](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-11).

## What did the tradipitant GLP-1 trials find?

Both trials used the same hard test. Adults with overweight or obesity and no diabetes (in phase 2, none had used a GLP-1 before) took tradipitant or a dummy capsule twice a day for about two weeks, and got one 1 mg shot of semaglutide with no dose climb before it[1](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-1) [2](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-2) [3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) [4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4). Each kept a daily diary of vomiting and of nausea on a 0 to 5 scale[1](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-1) [2](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-2). The main measure: how many people vomited at least once in the week after the shot[1](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-1) [2](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-2).

| Measure | Phase 2 (2025) | Phase 3, Study 3601 (2026) |
| --- | --- | --- |
| People analysed | 116 (58 per group)[4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4) | 306 (142 tradipitant, 164 placebo)[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) |
| Vomited at least once, tradipitant | 29.3%[4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4) | 43.0%[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) |
| Vomited at least once, placebo | 58.6%[4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4) | 58.5%[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) |
| Relative cut in vomiting | 50%[4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4) | 27%[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) |
| Vomiting plus a worst nausea score of 3 or more (0 to 5) | 22.4% vs 48.3%[4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4) | 33.1% vs 50.6%[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) |
| More than 10 vomiting episodes, a post hoc look | About 80% fewer[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) | 2.8% vs 14.6%[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) |

In phase 3 both prespecified results were statistically significant (p=0.006 for any vomiting, p=0.002 for vomiting with nausea)[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3). The bigger cuts in heavy vomiting came from analyses chosen after the data were in, which Vanda presents as supportive rather than proof[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3). Almost all vomiting in both groups happened by day 2 after the shot[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3). Vanda reported no new safety signals in either trial, and the results have not yet appeared in a journal as of November 20, 2026[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) [4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

## Does tradipitant stop the nausea or the vomiting?

Mainly the vomiting, on the evidence so far. On its motion-sickness boat trials, the approved label shows vomiting fell from 44% on placebo to 18 to 20% in one trial and from 38% to 10 to 18% in the other, while the worst nausea score was almost the same as placebo and the gap was not significant in either[6](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-6). The approval reads that way too: "prevention of vomiting induced by motion", not nausea[6](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-6) [7](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-7).

The GLP-1 trials point the same way. Their main measure is vomiting, and Vanda's planned filing names the prevention of vomiting with GLP-1 therapy[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) [5](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-5). The phase 3 trial also measured each person's worst nausea score over the week on its own[1](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-1), and Vanda's release gives no result for it[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3). So for someone whose problem is queasiness without vomiting, there is no trial answer yet.

## How close is the trial to real life on a GLP-1?

Not very, by design. Wegovy's label reaches 1 mg only in weeks 9 to 12, after two four-week steps at 0.25 and 0.5 mg, and the climb exists to lower stomach side effects[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12). The trials gave 1 mg on day one, which Vanda calls a rigorous test with a strong trigger[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) [4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4). That is why more than half of the placebo group vomited within a week, against far lower rates over months of treatment on the labels[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) [13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13):

| Setting | Vomiting on the drug | Vomiting on placebo |
| --- | --- | --- |
| Tradipitant phase 3: one 1 mg semaglutide shot, no climb, 1 week | 43.0% with tradipitant[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) | 58.5%[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3) |
| Wegovy 2.4 mg label: climb over 16 weeks, trials up to 68 weeks | 24%[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) | 6%[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) |
| Zepbound 15 mg label: climb up to 20 weeks, trials up to 72 weeks | 13%[13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13) | 2%[13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13) |

The rows count different people over different times, and the labels warn that rates across trials cannot be compared directly[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) [13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13). The gap shows what the trial asks: whether tradipitant blunts a heavy first hit, not whether it helps three months into a slow climb. Vanda says a pooled analysis of drug levels across both trials supports use at ordinary doses, without numbers yet[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3). Only semaglutide was tested. Vanda expects the effect to carry to every GLP-1 because tradipitant acts in the brain's vomiting centre[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3); for tirzepatide that is untested.

## What else has tradipitant been tested for?

| Use | What happened | When |
| --- | --- | --- |
| Motion sickness | Two boat trials met their goal; FDA approved Nereus to prevent vomiting caused by motion in adults | Approved December 30, 2025[7](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-7) [8](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-8) |
| Gastroparesis, a stomach that empties too slowly | Phase 2 met its nausea goal; the 12-week phase 3 in 201 adults missed its main goal (p=0.741)[10](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-10) [11](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-11) | FDA declined to approve on September 18, 2024; Vanda is challenging that in court[5](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-5) [11](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-11) |
| Itch in atopic dermatitis (eczema) | Phase 3 (EPIONE) missed its main itch goal; a second phase 3 was put on hold[11](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-11) | 2020; no longer in Vanda's pipeline list in October 2026[5](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-5) |

On the approved label, Nereus is a single 85 mg or 170 mg dose about an hour before travel, at most one dose a day, taken on an empty stomach[6](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-6). Its most common side effects were sleepiness, headache and tiredness, each in 12% or fewer on the higher dose[6](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-6). The label warns that it can affect driving, more so with other sedating medicines or with drugs that strongly block CYP3A4, one of the liver enzymes that clear it[6](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-6). The GLP-1 trials gave it twice a day for about two weeks, 85 mg per dose in phase 2[1](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-1) [4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4), a different schedule from the label; using it for GLP-1 sickness today would be off label, a prescriber's decision.

## When could tradipitant be approved for GLP-1 vomiting?

Not before Vanda files and the FDA reviews the filing. In its quarterly report of October 29, 2026, Vanda said it intends to discuss the phase 3 results with the FDA and plans to submit a supplemental application, the filing that adds a new use to an approved medicine, for preventing vomiting with GLP-1 therapy[5](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-5). Its release expects the FDA's feedback on that planned filing during 2027[3](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-3).

- **The registry:** the phase 3 record (NCT07446439), started March 27, 2026, still lists the status "recruiting", an estimated 280 people and an estimated primary completion of December 1, 2026; it was last updated on April 20, 2026, before the October results[1](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-1). The release analysed 306, more than the registry's estimate, and the phase 2 record lists 124 enrolled against the 116 its release analysed[2](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-2) [4](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-4).
- **A journal paper:** not published as of November 20, 2026; when it is, this guide will add the nausea-only result and the side effects by group.
- **The FDA:** no filing or decision reported as of November 20, 2026. This section will carry the filing date and the decision when they come.

## What helps with GLP-1 nausea right now?

Nausea is the most common side effect of these shots: on Wegovy 2.4 mg 44% reported it against 16% on placebo, on Zepbound 25 to 29% against 8%, and Zepbound's label notes most stomach effects came during the climb and decreased over time[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) [13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13). The steps below come from the labels and an expert panel[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) [13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13) [14](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-14):

1. Follow the climb your prescriber set; if a step is too rough, ask about staying on the lower dose longer: Wegovy's label tells prescribers to consider delaying the next step by four weeks[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12).
2. Serve a smaller portion, eat slowly, and stop as soon as you feel full[14](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-14).
3. Choose plain, low-fat food, baked, grilled or boiled, over fatty or spicy food and rich sauces[14](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-14).
4. Stay upright after eating, and leave a gap before bed[14](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-14).
5. Sip fluids through the day, more on any day with vomiting or diarrhoea, since losing fluid can strain the kidneys[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) [13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13) [14](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-14).
6. If nausea keeps coming back despite this, ask your prescriber about an anti-sickness medicine; the panel suggests considering one when nausea persists[14](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-14).

**Commonly reported:** queasiness worst a day or two after the shot and after each step-up, fatty food losing its appeal, and sulphur-tasting burps after a heavy meal.

<!--promo-->

PepVault's side-effect log keeps each symptom with the compound, a severity from minimal to very severe, the date and a note, so you can show your prescriber which step and which days it hit. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-tradipitant-for-glp-1-nausea-inlin&mt=8)

<!--/promo-->

<!--promo-->

Its dose reminders keep your weekly shot day steady, and the dose log keeps each shot with its date and the step-ups your prescriber set, as you enter them. [Set reminders in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-tradipitant-for-glp-1-nausea-inlin&mt=8)

<!--/promo-->

**When to get help** Both labels say to tell your healthcare provider right away about nausea, vomiting or diarrhoea that does not go away, and to drink fluids to lower the chance of dehydration[12](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-12) [13](https://pepvault.app/guides/tradipitant-for-glp-1-nausea#source-13).

Next: our guides to Ozempic and Wegovy side effects and to Mounjaro and Zepbound side effects give every label rate and how long nausea lasts.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. ClinicalTrials.gov NCT07446439. The Thetis Study: tradipitant on nausea and vomiting after GLP-1R agonist administration (VP-VLY-686-3601). Sponsor Vanda Pharmaceuticals. Record last updated April 20, 2026; read November 20, 2026. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07446439)
2. ClinicalTrials.gov NCT06804603. Proof-of-concept study of tradipitant on nausea and vomiting after GLP-1R agonist administration (VP-VLY-686-2601). Sponsor Vanda Pharmaceuticals. Completed October 6, 2025. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06804603)
3. Vanda Pharmaceuticals. Vanda Pharmaceuticals announces positive results from Study 3601 of NEREUS (tradipitant) for prevention of GLP-1-induced vomiting. Press release, PR Newswire, October 27, 2026 (not filed as an SEC exhibit; the October 28, 2026 Form 8-K, Exhibit 99.1, confirms the results were announced). [prnewswire.com](https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-positive-results-from-study-3601-of-nereus-tradipitant-for-prevention-of-glp-1induced-vomiting-302920054.html)
4. Vanda Pharmaceuticals. Vanda reports positive results for tradipitant in preventing GLP-1 induced nausea and vomiting. Press release, PR Newswire, November 17, 2025. [prnewswire.com](https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-reports-positive-results-for-tradipitant-in-preventing-glp-1-induced-nausea-and-vomiting-302617739.html)
5. Vanda Pharmaceuticals Inc. Form 10-Q for the quarter ended September 30, 2026, filed with the SEC October 29, 2026. [sec.gov](https://www.sec.gov/Archives/edgar/data/1347178/000134717826000002/vnda-20260930.htm)
6. NEREUS (tradipitant) capsules prescribing information, DailyMed (SPL version 5; label effective September 1, 2026, published on DailyMed October 19, 2026). Sections 1, 2, 5, 6, 7, 12 and 14. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a021ebd-16ac-4354-b4b2-1c3950c091e5)
7. US Food and Drug Administration. NDA 220152 (NEREUS, tradipitant) approval letter, December 30, 2025. Drugs@FDA. [accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/220152Orig1s000ltr.pdf)
8. Vanda Pharmaceuticals. Vanda announces FDA approval of NEREUS (tradipitant) for the prevention of vomiting induced by motion. Press release, December 30, 2025 (Form 8-K, Exhibit 99.1). [sec.gov](https://www.sec.gov/Archives/edgar/data/1347178/000162828025059155/vnda8-k12302025exhibit991.htm)
9. EMEND (aprepitant) capsules and oral suspension prescribing information, DailyMed (published November 6, 2026). Sections 1 and 12.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=696f9e80-9cae-403b-de9e-078343ce4713)
10. Carlin JL et al. The efficacy of tradipitant in patients with diabetic and idiopathic gastroparesis in a phase 3 randomized placebo-controlled clinical trial. Clin Gastroenterol Hepatol. 2024. [PubMed 38237696](https://pubmed.ncbi.nlm.nih.gov/38237696/)
11. Vanda Pharmaceuticals Inc. Form 10-K for the year ended December 31, 2025, filed with the SEC February 12, 2026. [sec.gov](https://www.sec.gov/Archives/edgar/data/1347178/000162828026007460/vnda-20251231.htm)
12. WEGOVY (semaglutide) injection and tablets prescribing information, DailyMed (SPL version 19; label updated June 18, 2026, published on DailyMed June 30, 2026). Sections 2, 5, 6.1 (Table 3) and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
13. ZEPBOUND (tirzepatide) injection prescribing information, DailyMed (SPL version 40; label updated August 28, 2026, published on DailyMed September 2, 2026). Sections 2, 5, 6.1 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
14. Gorgojo-Martínez JJ et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2023. [PubMed 36614945](https://pubmed.ncbi.nlm.nih.gov/36614945/)
15. Polymeropoulos VM et al. Motion Syros: tradipitant effective in the treatment of motion sickness; a multicenter, randomized, double-blind, placebo-controlled study. Front Neurol. 2025. [PubMed 40103934](https://pubmed.ncbi.nlm.nih.gov/40103934/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)

Do Ozempic, Wegovy, Mounjaro or Zepbound cause depression? The FDA's 2026 review, the labels' warning removed, the trial rates against placebo, and what helps.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)

## Related guides

- Guide · GLP-1s

  ### [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)

  Ozempic and Wegovy side effects from the labels' trials, drug against placebo: nausea and the rest, when they start, how many days they last, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)

  Mounjaro and Zepbound side effects at 5, 10 and 15 mg against placebo, from the labels' trial tables: when they show up, how many stopped, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)

  Semaglutide vs tirzepatide side effects in the same trials: nausea, vomiting, reflux, hair loss and injection-site rates side by side, and how many stopped.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
